I am an ordinary investor who invests in stocks and pays attention to cryptocurrencies, always looking for opportunities to combine the two. It wasn't until Injective launched its RWA business that I truly experienced the convenience of 'on-chain investment in global assets.' As the first project to bring assets like stocks, gold, and foreign exchange onto the chain, Injective's RWA revolution not only changes traditional investment models but also reshapes my understanding of asset allocation.
The first time I traded on-chain stock tokens on Injective, I was amazed by its convenience. Previously, investing in U.S. stocks required opening an overseas securities account, facing a series of issues such as cross-border funds, limited trading hours, and high fees. Additionally, the minimum trading unit is 1 share; for high-priced stocks like Nvidia, a single lot costs tens of thousands of dollars, which is a high barrier. However, on Injective, after stocks are tokenized, they can be held fractionally. I only spent a few hundred dollars to buy a portion of Nvidia stock tokens, and trading is available 24/7, meaning I can buy and sell at any time, regardless of late nights or weekends, completely unrestricted by traditional stock market trading hours. More importantly, the transaction settlement is almost real-time, unlike the traditional stock market which requires a T+2 settlement cycle, greatly improving capital utilization.
The reason Injective's RWA business can achieve this lies in its technical architecture and compliance design. Built on Layer-2 technology, it not only addresses the performance bottlenecks of the underlying public chain but also ensures transaction privacy and security through zero-knowledge proof technology. In the process of asset tokenization, Injective has introduced professional asset custodians to ensure that on-chain tokens are fully anchored to the value of the underlying assets. All transactions are executed automatically through smart contracts, eliminating the risk of human intervention. I have specifically studied its gold tokenization mechanism, where each on-chain gold token corresponds to the ownership of physical gold, allowing investors to redeem physical gold at any time, which addresses many people's concerns about whether 'virtual assets have real value backing'.
In addition to stocks and gold, Injective is also bringing assets like foreign exchange onto the chain, which has diversified my asset allocation. Previously, ordinary investors faced complex leverage mechanisms and high trading costs when trying to participate in foreign exchange trading. However, Injective's on-chain foreign exchange tokens eliminate leverage risks and allow for small, diversified investments. My current asset allocation includes traditional stocks and funds, cryptocurrencies, as well as RWA assets on Injective. This diversified allocation not only reduces the risks associated with single market volatility but also allows me to capture investment opportunities across different markets.
The $100 million funding injection from Pineapple Financial has boosted my confidence in Injective's RWA ecosystem. This funding will not only be used to purchase INJ tokens but will also support the ongoing onboarding of RWA assets and ecosystem development. As more high-quality assets are integrated, Injective's RWA ecosystem will become increasingly refined, and liquidity will continue to improve. In the future, I look forward to seeing more high-quality assets from various industries tokenized, such as real estate and intellectual property, allowing ordinary investors to participate in investments that previously had very high barriers to entry.
The RWA revolution of Injective essentially makes investment fairer, more convenient, and more efficient. It breaks down the barriers of traditional financial markets, making global assets accessible. As a firsthand participant, I have deeply felt the dividends brought by this transformation. I believe that as technology continues to mature and the ecosystem continues to grow, Injective will become the world's largest RWA trading platform, and INJ, as the core token of the ecosystem, will play an important role in various scenarios such as asset trading, fee settlement, and ecosystem governance, with its value continuously increasing alongside the prosperity of the ecosystem.
